Mostra el registre parcial de l'element
dc.contributor.author | Hurtado Sarrió, Mercedes | |
dc.contributor.author | Duch Samper, Antonio Miguel | |
dc.contributor.author | Cisneros Lanuza, Angel | |
dc.contributor.author | Díaz Llopis, Manuel | |
dc.contributor.author | Pemán Garcia, Francisco Javier | |
dc.contributor.author | Vazquez Polo, A. | |
dc.date.accessioned | 2020-03-11T08:22:56Z | |
dc.date.available | 2020-03-11T08:22:56Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Hurtado Sarrió, Mercedes Duch Samper, Antonio Miguel Cisneros Lanuza, Angel Díaz Llopis, Manuel Pemán Garcia, Francisco Javier Vazquez Polo, A. 2010 Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole Archives of Ophthalmology 128 7 941 942 | |
dc.identifier.uri | https://hdl.handle.net/10550/73519 | |
dc.description.abstract | Fungal keratitis is an important ophthalmic problem because it leads to corneal blindness and sometimes to loss of the eye.1,2 There is no agreed protocol for the treatment of suspected fungal keratitis. Topical and oral voriconazole have now been reported to be effective.3 However, some cases do not respond to this treatment. New antifungal agents such as caspofungin acetate, 0.5%, are promising alternatives | |
dc.language.iso | eng | |
dc.relation.ispartof | Archives of Ophthalmology, 2010, vol. 128, num. 7, p. 941-942 | |
dc.subject | Fongs patògens | |
dc.title | Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole | |
dc.type | journal article | es_ES |
dc.date.updated | 2020-03-11T08:22:56Z | |
dc.identifier.doi | 10.1001/archophthalmol.2010.110 | |
dc.identifier.idgrec | 107206 | |
dc.rights.accessRights | open access | es_ES |